WEST CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--BTG plc (LSE:BTG), the specialist healthcare company, announced that the U.S. Food and Drug Administration has approved an extension of the post-activation ...
BOTHELL, WA, April 29, 2019 /PRNewswire/ -- BTG plc (LSE: BTG), the global specialist healthcare company, today highlighted the VIEW VLU Registry interim study results, presented at the International ...
BTG plc (LSE: BTG), the specialist healthcare company, today announces that the US Food and Drug Administration (FDA) has approved Varithena™ (polidocanol injectable foam) for the treatment of ...
OTTAWA, Jan. 26, 2017 /CNW/ - BTG International Canada Inc., part of global specialist healthcare company BTG (LSE: BTG), today announced the Canadian commercial launch of Varithena ™ (polidocanol ...
UK healthcare company BTG passed a major milestone this week when the US Food and Drug Administration (FDA) approved Varithena, a treatment for varicose veins which has followed a long and tortuous ...
BTG has finally got the green light in the USA for Varithena, the UK group's varicose veins treatment. BTG has finally got the green light in the USA for Varithena, the UK group’s varicose veins ...
BTG plc (LSE: BTG), the specialist healthcare company, today announces that Health Canada has issued a Notice of Compliance approving Varithena™ (polidocanol injectable foam), a prescription medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback